Literature DB >> 1145149

Sarcoid reactions in pulmonary neoplasms.

P Laurberg.   

Abstract

In a consectuive series of 734 patients with malignant tumorous of the lung, sarcoid reactions were observed in the mediastinal lymph nodes in 20 cases, i.e. in 3.2% of the 630 patients in whom these nodes were studied. Among these 20 patients, sarcoidosis was suspected in three. In two of these, granulomata were revealed in the tumour. Another two had metastases in the affected lymph nodes. All the common histological types of lung tumour were represented in the patients, but squamous-cell carcinomata showed a statistically significant preponderance as compared with anaplastic carcinomata. Three causes of such sarcoid reactions have been suggested: 1. an immunological reaction to substances released by the tumour and transported along the lymphatics; 2. an unrecognized sarcoidosis predisposing to lung cancer; 3. the co-existence of sarcoidosis and malignant tumour, possibly due to a common aetiological factor. The significant preponderance of squamous-cell carcinomata observed in this study is in favour of the first theory, because the slower growth and higher tendency to necrosis of this tumour type may be assumed to give rise to a more vigorous and longer-lasting stimulation of the regional lymph nodes.

Entities:  

Mesh:

Year:  1975        PMID: 1145149

Source DB:  PubMed          Journal:  Scand J Respir Dis        ISSN: 0036-5572


  9 in total

1.  Pulmonary small cell carcinoma associated with sarcoid reactions: report of a case.

Authors:  M Kamiyoshihara; T Hirai; O Kawashima; S Ishikawa; Y Morishita
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

2.  Prolactinoma coexistent with granulomatous hypophysitis.

Authors:  S Holck; H Laursen
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

3.  Sarcoidosis development during induction chemotherapy for lung cancer mimicked progressive disease.

Authors:  Hideo Umezu; Masayuki Chida; Takashi Inoue; Osamu Araki; Motohiko Tamura; Masamitsu Tatewaki; Yasutsugu Fukushima; Koichi Honma
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-08-12

Review 4.  A case of resectable lung adenocarcinoma associated with sarcoidosis.

Authors:  H Yanagawa; H Goto; K Maniwa; F Ogushi; K Takahashi; Y Monden; T Hirose; N Sano; S Sone
Journal:  Med Oncol       Date:  1999-09       Impact factor: 3.064

5.  False positive accumulation in 18F fluorodeoxyglucose positron emission tomography scan due to sarcoid reaction following induction chemotherapy for lung cancer.

Authors:  Jun Maeda; Mitsunori Ohta; Hirohisa Hirabayashi; Hikaru Matsuda
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2005-04

6.  Significance of coexistent granulomatous inflammation and lung cancer.

Authors:  Rucha S Dagaonkar; Caroline V Choong; Atasha Binti Asmat; Dokeu Basheer A Ahmed; Akhil Chopra; Albert Y H Lim; Dessmon Y H Tai; Ai Ching Kor; Soon Keng Goh; John Abisheganaden; Akash Verma
Journal:  J Clin Pathol       Date:  2016-09-19       Impact factor: 3.411

7.  Angiotensin-converting enzyme and its association with outcome in lung cancer.

Authors:  F K Rømer
Journal:  Br J Cancer       Date:  1981-02       Impact factor: 7.640

8.  Does Every Necrotizing Granulomatous Inflammation Identified by NSCLC Resection Material Require Treatment?

Authors:  Fatih Yakar; Aysun Yakar; Nur Büyükpınarbaşılı; Mustafa Erelel
Journal:  Med Sci Monit       Date:  2016-04-11

9.  The combination of EBUS-TBNA and the PAB antibody led to a successful treatment for lung cancer in a patient with asymptomatic sarcoidosis mimicking nodal metastasis.

Authors:  Mari Tone; Nobuyasu Awano; Minoru Inomata; Naoyuki Kuse; Tatsunori Jo; Hanako Yoshimura; Yoshiaki Furuhata; Tamiko Takemura; Toshio Kumasaka; Takehiro Izumo
Journal:  Respir Med Case Rep       Date:  2018-10-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.